Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice
- PMID: 7540941
- DOI: 10.1016/1074-7613(95)90001-2
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice
Abstract
Understanding the immunological mechanisms of protection and pathogenesis in tuberculosis remains problematic. We have examined the extent to which tumor necrosis factor-alpha (TNF alpha) contributes to this disease using murine models in which the action of TNF alpha is inhibited. TNF alpha was neutralized in vivo by monoclonal antibody; in addition, a mouse strain with a disruption in the gene for the 55 kDa TNF receptor was used. The data from both models established that TNF alpha and the 55 kDa TNF receptor are essential for protection against tuberculosis in mice, and for reactive nitrogen production by macrophages early in infection. Granulomas were formed in equal numbers in control and experimental mice, but necrosis was observed only in mice deficient in TNF alpha or TNF receptor. TNF alpha and the 55 kDa TNF receptor are necessary conditions for protection against murine M. tuberculosis infection, but are not solely responsible for the tissue damage observed.
Similar articles
-
The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes.J Immunol. 2003 May 15;170(10):5210-8. doi: 10.4049/jimmunol.170.10.5210. J Immunol. 2003. PMID: 12734369
-
High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas.Eur J Immunol. 1997 Dec;27(12):3182-90. doi: 10.1002/eji.1830271215. Eur J Immunol. 1997. PMID: 9464804
-
A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice.J Leukoc Biol. 2000 Oct;68(4):538-44. J Leukoc Biol. 2000. PMID: 11037976
-
TNF-alpha in tuberculosis: a cytokine with a split personality.Inflamm Allergy Drug Targets. 2009 Mar;8(1):53-62. doi: 10.2174/187152809787582543. Inflamm Allergy Drug Targets. 2009. PMID: 19275693 Review.
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
Cited by
-
Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor.Korean J Intern Med. 2013 Mar;28(2):174-9. doi: 10.3904/kjim.2013.28.2.174. Epub 2013 Feb 27. Korean J Intern Med. 2013. PMID: 23525649 Free PMC article.
-
Production of Proinflammatory Cytokines by CD4+ and CD8+ T Cells in Response to Mycobacterial Antigens among Children and Adults with Tuberculosis.Pathogens. 2023 Nov 14;12(11):1353. doi: 10.3390/pathogens12111353. Pathogens. 2023. PMID: 38003817 Free PMC article.
-
Dynamics of immune effector mechanisms during infection with Mycobacterium avium in C57BL/6 mice.Immunology. 2013 Oct;140(2):232-43. doi: 10.1111/imm.12131. Immunology. 2013. PMID: 23746054 Free PMC article.
-
Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection.Sci Rep. 2013;3:1809. doi: 10.1038/srep01809. Sci Rep. 2013. PMID: 23657146 Free PMC article.
-
Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.Clin Rev Allergy Immunol. 2013 Apr;44(2):121-40. doi: 10.1007/s12016-012-8301-7. Clin Rev Allergy Immunol. 2013. PMID: 22311162 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases